Cargando…

Metabolomic credentialing of murine carcinogen-induced urothelial cancer

Bladder cancer (BCa) is the most common malignancy of the urinary system with increasing incidence, mortality, and limited treatment options. Therefore, it is imperative to validate preclinical models that faithfully represent BCa cellular, molecular, and metabolic heterogeneity to develop new thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Afify, Hesham, Ghoneum, Alia, Almousa, Sameh, Abdulfattah, Ammar Yasser, Warren, Bailey, Langsten, Kendall, Gonzalez, Daniela, Casals, Randy, Bharadwaj, Manish, Kridel, Steven, Said, Neveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585868/
https://www.ncbi.nlm.nih.gov/pubmed/34764423
http://dx.doi.org/10.1038/s41598-021-99746-3
_version_ 1784597773927055360
author Afify, Hesham
Ghoneum, Alia
Almousa, Sameh
Abdulfattah, Ammar Yasser
Warren, Bailey
Langsten, Kendall
Gonzalez, Daniela
Casals, Randy
Bharadwaj, Manish
Kridel, Steven
Said, Neveen
author_facet Afify, Hesham
Ghoneum, Alia
Almousa, Sameh
Abdulfattah, Ammar Yasser
Warren, Bailey
Langsten, Kendall
Gonzalez, Daniela
Casals, Randy
Bharadwaj, Manish
Kridel, Steven
Said, Neveen
author_sort Afify, Hesham
collection PubMed
description Bladder cancer (BCa) is the most common malignancy of the urinary system with increasing incidence, mortality, and limited treatment options. Therefore, it is imperative to validate preclinical models that faithfully represent BCa cellular, molecular, and metabolic heterogeneity to develop new therapeutics. We performed metabolomic profiling of premalignant and non-muscle invasive bladder cancer (NMIBC) that ensued in the chemical carcinogenesis N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model. We identified the enriched metabolic signatures that associate with premalignant and NMIBC. We found that enrichment of lipid metabolism is the forerunner of carcinogen-induced premalignant and NMIBC lesions. Cross-species analysis revealed the prognostic value of the enzymes associated with carcinogen-induced enriched metabolic in human disease. To date, this is the first study describing the global metabolomic profiles associated with early premalignant and NMIBC and provide evidence that these metabolomic signatures can be used for prognostication of human disease.
format Online
Article
Text
id pubmed-8585868
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85858682021-11-12 Metabolomic credentialing of murine carcinogen-induced urothelial cancer Afify, Hesham Ghoneum, Alia Almousa, Sameh Abdulfattah, Ammar Yasser Warren, Bailey Langsten, Kendall Gonzalez, Daniela Casals, Randy Bharadwaj, Manish Kridel, Steven Said, Neveen Sci Rep Article Bladder cancer (BCa) is the most common malignancy of the urinary system with increasing incidence, mortality, and limited treatment options. Therefore, it is imperative to validate preclinical models that faithfully represent BCa cellular, molecular, and metabolic heterogeneity to develop new therapeutics. We performed metabolomic profiling of premalignant and non-muscle invasive bladder cancer (NMIBC) that ensued in the chemical carcinogenesis N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model. We identified the enriched metabolic signatures that associate with premalignant and NMIBC. We found that enrichment of lipid metabolism is the forerunner of carcinogen-induced premalignant and NMIBC lesions. Cross-species analysis revealed the prognostic value of the enzymes associated with carcinogen-induced enriched metabolic in human disease. To date, this is the first study describing the global metabolomic profiles associated with early premalignant and NMIBC and provide evidence that these metabolomic signatures can be used for prognostication of human disease. Nature Publishing Group UK 2021-11-11 /pmc/articles/PMC8585868/ /pubmed/34764423 http://dx.doi.org/10.1038/s41598-021-99746-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Afify, Hesham
Ghoneum, Alia
Almousa, Sameh
Abdulfattah, Ammar Yasser
Warren, Bailey
Langsten, Kendall
Gonzalez, Daniela
Casals, Randy
Bharadwaj, Manish
Kridel, Steven
Said, Neveen
Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title_full Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title_fullStr Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title_full_unstemmed Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title_short Metabolomic credentialing of murine carcinogen-induced urothelial cancer
title_sort metabolomic credentialing of murine carcinogen-induced urothelial cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585868/
https://www.ncbi.nlm.nih.gov/pubmed/34764423
http://dx.doi.org/10.1038/s41598-021-99746-3
work_keys_str_mv AT afifyhesham metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT ghoneumalia metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT almousasameh metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT abdulfattahammaryasser metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT warrenbailey metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT langstenkendall metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT gonzalezdaniela metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT casalsrandy metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT bharadwajmanish metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT kridelsteven metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer
AT saidneveen metabolomiccredentialingofmurinecarcinogeninducedurothelialcancer